March 19, 2013

Gain-of-Function Research on HPAI H5N1 Viruses: Welcome and Introductory Remarks

Day 1
8:00 -- 9:00 A.M. Introductory Remarks

Sally Howard, J.D., Chief of Staff, U.S. Department of Health and Human Services

Meeting Co-Moderators:
Robbert Dijkgraaf, Ph.D., Co-chair, InterAcademy Council

Past President, the Royal Netherlands Academy of Arts and Sciences, the Netherlands

Director and Leon Levy Professor, Institute for Advanced Study, Princeton, USA

  • Harvey Fineberg, M.D., Ph.D., President, Institute of Medicine, National Academies
  • Professor of Health Policy and Management, Emeritus, Department of Health Policy and Management, Harvard University, USA


  • Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
  • Amy P. Patterson, M.D., Associate Director for Science Policy, National Institutes of Health, USA

The presentations in the opening session will set the stage for the Workshop by briefly highlighting the scientific, public health, biosafety, and biosecurity issues surrounding HPAI H5N1 research that increases transmissibility, pathogenicity, and/or host range; introducing the concept that HHS has developed a draft Framework for guiding funding decisions about proposed HPAI H5N1 GOF research; and noting that the meeting participants will have the opportunity to exercise this Framework through discussion of a series of case studies. The global nature of the research and the benefits and risks associated with it underscore the importance of hearing a broad range of perspectives about the responsible funding and conduct of such research. Discussions over this 2-day workshop will be carefully considered as HHS finalizes its Framework.

This page last reviewed on April 20, 2015